Drug discontinuation: Lincomycin Hydrochloride Injection (LINCOMYCIN, LINCOCIN)
FDA lists 3 presentations as To Be Discontinued. Companies: XGen Pharmaceuticals DJB, Inc., Pfizer Inc..
- Published by source
- 2026-02-25
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- XGen Pharmaceuticals DJB, Inc.
- Products
- Lincomycin Hydrochloride Injection LINCOMYCIN LINCOCIN
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- A business decision was made to discontinue manufacture of the drug.
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-02-25
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #958 | new | 2026-10-22 | 51eac2f4904d…0cd910 | cc4ca11939eb…2cd079 |
Chain head: #1076 8ad5adc30b9b…88ce20